APA

Van Schaeybroeck S., Kalimutho M., Dunne P. D., Carson R., Allen W., Jithesh P. V., Redmond K. L., Sasazuki T., Shirasawa S., Blayney J., Michieli P., Fenning C., Lenz H., Lawler M., Longley D. B. & Johnston P. G. (20150416). ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. : Cell reports.

Chicago

Van Schaeybroeck Sandra, Kalimutho Murugan, Dunne Philip D, Carson Robbie, Allen Wendy, Jithesh Puthen V, Redmond Keara L, Sasazuki Takehiko, Shirasawa Senji, Blayney Jaine, Michieli Paolo, Fenning Cathy, Lenz Heinz-Josef, Lawler Mark, Longley Daniel B and Johnston Patrick G. 20150416. ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. : Cell reports.

Harvard

Van Schaeybroeck S., Kalimutho M., Dunne P. D., Carson R., Allen W., Jithesh P. V., Redmond K. L., Sasazuki T., Shirasawa S., Blayney J., Michieli P., Fenning C., Lenz H., Lawler M., Longley D. B. and Johnston P. G. (20150416). ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. : Cell reports.

MLA

Van Schaeybroeck Sandra, Kalimutho Murugan, Dunne Philip D, Carson Robbie, Allen Wendy, Jithesh Puthen V, Redmond Keara L, Sasazuki Takehiko, Shirasawa Senji, Blayney Jaine, Michieli Paolo, Fenning Cathy, Lenz Heinz-Josef, Lawler Mark, Longley Daniel B and Johnston Patrick G. ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. : Cell reports. 20150416.